Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Growth Rate is Forecasted for the ACE Inhibitors Market over the 2024-2033 Period?
The market size of ace inhibitors has seen consistent expansion in the past few years. The market, which is expected to escalate from $6.9 billion in 2023 to $7.24 billion in 2024, predicts a Compound Annual Growth Rate (CAGR) of 4.9%. The historical growth is linked to factors such as a surge in cardiovascular disease occurrence, an upturn in the aging population, clinical efficiency and safety measures, a rise in diabetes cases, and regulatory approvals and guidelines.
The marketplace for ace inhibitors is predicted to experience substantial expansion in the coming years. The market value is estimated to reach $9 billion by 2028, with a compound annual growth rate (CAGR) of 5.6%. Factors contributing to this projected growth include the escalating worldwide count of cardiovascular ailments, broadened hypertension treatment methodologies, innovations in combination therapies, emphasis on controlling heart failure, and increased awareness and healthcare accessibility. Notable trends within this period will center on kidney protection, a preference for renin-angiotensin system inhibitors, competition among generics and pricing challenges, patient-oriented strategies in healthcare, and updates in regulations and safety considerations.
Claim Your Free Sample of the Global ACE Inhibitors Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10671&type=smp
Which Factors Are Stimulating Growth in the ace inhibitors Market?
The escalation in hypertension disorders is anticipated to propel the growth of the ACE inhibitors market. Hypertension, or high blood pressure, which is medically defined as a state of increased pressure in blood vessels, has become increasingly common. ACE inhibitors, also known as angiotensin-converting enzyme inhibitors, are a category of drugs used to manage and control hypertension, working by relaxing the blood vessels and thereby reducing blood pressure and enhancing blood flow. As of March 2023, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported around 1.28 billion adults from 30 to 79 years of age globally were struggling with hypertension, with the majority originating from low- and middle-income countries. There has been a rise of 650 million people aged 30-79 suffering from hypertension over the last 30 years. Approximately 46% of adults with hypertension do not know about it because they have not been diagnosed. Thus, the increased occurrence of hypertension disorders is stimulating the ACE inhibitors market.
What Are the Main Segments of the ACE Inhibitors Market?
1) By Type: Sulfhydryl-containing Agents, Dicarboxylate-containing Agents, Phosphonate-containing Agents
2) By Drug: Ramipril, Enalapril, Benazepril, Fosinopril, Captopril, Moexipril, Other Drugs
3) By Dosage Form: Oral Tablets, Oral Solutions
4) By Application: Heart Failure, Chronic Kidney Disease, Hypertension, Diabetes, Heart Attack, Other Applications
5) By End-Users: Hospitals, Online Drug Stores, Other End-Users
What Innovative Trends Are Redefining the ACE Inhibitors Landscape?
In the ACE inhibitors market, a rising trend is the focus on product innovations. To consolidate their positions and achieve a competitive edge, key companies in this market are concentrating on the creation of innovative products. For instance, Travere Therapeutics, a biopharmaceutical company from the US, received FDA approval for FILSPARI™ (sparsentan) in February 2023. This innovative product is a unique non-immunosuppressive treatment for patients suffering from IgA Nephropathy (IgAN). It encompasses systemic glucocorticoids, ACE inhibitors, and antihypertensive medicines including angiotensin-receptor blockers (ARBs). This treatment stands out as the only approved non-immunosuppressive therapy and is a once-daily oral medication designed to treat adults afflicted with primary IgAN who are at a high risk of speedy disease progression and typically possess a UPCR of less than 1.5 g/g and proteinuria.
Order Now for Fast Delivery of Your ACE Inhibitors Market Report!
https://www.thebusinessresearchcompany.com/report/ace-inhibitors-global-market-report
Which Regions Are Key Players in the Growth of the ACE Inhibitors Market?
North America was the largest region in the ACE inhibitors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global ACE inhibitors market report during the forecast period. The regions covered in the ace inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The ACE Inhibitors Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the ace inhibitors market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The ACE Inhibitors Market Include
1. ACE Inhibitors Market Executive Summary
2. ACE Inhibitors Market Segments
3. ACE Inhibitors Market Size And Template Market Growth Rate
4. Key ACE Inhibitors Market Trends
5. Major ACE Inhibitors Market Drivers
……
25. Key Mergers And Acquisitions In The ACE Inhibitors Market
26. Top ACE Inhibitors Companies
27. ACE Inhibitors Market Opportunities And Strategies
28. ACE Inhibitors Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Specialty Enzymes Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/specialty-enzyme-global-market-report
Digestive Enzymes Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/digestive-enzyme-global-market-report
Synthetic Biology Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
